Stocks and Investing Stocks and Investing
Thu, May 25, 2023
Wed, May 24, 2023

Gil Blum Reiterated (SRPT) at Strong Buy and Held Target at $185 on, May 24th, 2023


Published on 2024-10-28 04:00:05 - WOPRAI, Gil Blum
  Print publication without navigation


Gil Blum of Needham, Reiterated "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy and Held Target at $185 on, May 24th, 2023.

Gil has made no other calls on SRPT in the last 4 months.



There are 15 other peers that have a rating on SRPT. Out of the 15 peers that are also analyzing SRPT, 1 agrees with Gil's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Judah Frommer of "Credit Suisse" Maintained at Hold with Increased Target to $151 on, Monday, May 15th, 2023


These are the ratings of the 14 analyists that currently disagree with Gil


  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $218 on, Tuesday, May 16th, 2023
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $173 on, Monday, May 15th, 2023
  • Gavin Clark-Gartner of "Evercore ISI Group" Maintained at Buy with Increased Target to $173 on, Monday, May 15th, 2023
  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Increased Target to $176 on, Monday, May 15th, 2023
  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $158 on, Wednesday, May 3rd, 2023
  • David Hoang of "SMBC Nikko" Initiated at Buy and Held Target at $185 on, Wednesday, April 26th, 2023
  • Uy Ear of "Mizuho" Reiterated at Strong Buy and Held Target at $160 on, Friday, April 14th, 2023
  • Neena Bitritto-Garg of "Citigroup" Initiated at Strong Buy and Held Target at $179 on, Tuesday, April 4th, 2023
  • Ritu Baral of "TD Cowen" Maintained at Buy with Increased Target to $175 on, Wednesday, March 22nd, 2023
  • Hartaj Singh of "Oppenheimer" Maintained at Buy with Decreased Target to $150 on, Thursday, March 9th, 2023
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $206 on, Friday, March 3rd, 2023
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $190 on, Wednesday, March 1st, 2023
  • Matthew Harrison of "Morgan Stanley" Upgraded from Hold to Buy and Increased Target to $187 on, Wednesday, March 1st, 2023
  • Brian Skorney of "Baird" Maintained at Buy with Increased Target to $202 on, Wednesday, March 1st, 2023
Contributing Sources